FDA inspection
Milla Pharmaceuticals, Inc.: FDA inspection ending Mar 12, 2026
FDA inspection 1306944 · No Action Indicated (NAI) · Saint Paul, MN
Key facts
| Inspection ID | 1306944 |
|---|---|
| Firm | Milla Pharmaceuticals, Inc. |
| FEI number | 3015401429 |
| Address | 1310 Highway 96 E Ste 104a |
| City | Saint Paul |
| State | MN |
| ZIP | 55110 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Mar 12, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data